Antonio Rullan
Impact in
- Ophthalmology top 5%
- Ocular Oncology and Treatments
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- interferon and immune responses
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 8
- CAR-T cell therapy research 4
- Cancer Cells and Metastasis 3
- Immunology 10
- Immunotherapy and Immune Responses 7
- Co-authors
- Erik Sahai (6 shared papers)Danielle Park (2 shared papers)Josep M. Piulats (2 shared papers)Ignacio Melero (2 shared papers)Alfonso R. Sánchez-Paulete (1 shared paper)María E. Rodríguez-Ruiz (2 shared papers)Nicola Tinari (1 shared paper)Marc Oliva (1 shared paper)
- Journals
- Journal of Clinical Oncology (3 papers)Frontiers in Oncology (3 papers)Blood (2 papers)Cancer Treatment Reviews (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United KingdomSpainPalestinian Territory
In The Last Decade
Antonio Rullan
28 papers receiving 965 citations
Peers
Comparison fields: 5 of 90
- Ophthalmology 171
- Immunology 382
- Oncology 426
- Otorhinolaryngology 48
- Cancer Research 117
Countries citing papers authored by Antonio Rullan
This map shows the geographic impact of Antonio Rullan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Rullan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Rullan more than expected).
Fields of papers citing papers by Antonio Rullan
This network shows the impact of papers produced by Antonio Rullan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Rullan. The network helps show where Antonio Rullan may publish in the future.
Co-authors
The 25 scholars most cited alongside Antonio Rullan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 166 | |
| 2 | 2021 | 145 | |
| 3 | 2020 | 119 | |
| 4 | 2010 | 91 | |
| 5 | 2021 | 86 | |
| 6 | 2020 | 72 | |
| 7 | 2016 | 65 | |
| 8 | 2019 | 54 | |
| 9 | 2015 | 29 | |
| 10 | 2019 | 26 | |
| 11 | 2022 | 23 | |
| 12 | 2022 | 21 | |
| 13 | 1956 | 18 | |
| 14 | 2024 | 12 | |
| 15 | 2024 | 10 | |
| 16 | 2022 | 10 | |
| 17 | 2023 | 6 | |
| 18 | 2024 | 6 | |
| 19 | 1962 | 5 | |
| 20 | 2024 | 4 |
About Antonio Rullan
Antonio Rullan is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 31 papers that have together received 987 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Immunotherapy and Immune Responses (7 papers), CAR-T cell therapy research (4 papers), Virus-based gene therapy research (3 papers), Cancer Cells and Metastasis (3 papers), Head and Neck Cancer Studies (3 papers), Nanoplatforms for cancer theranostics (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Ophthalmology (171 citations), Immunology (382 citations), Oncology (426 citations), Otorhinolaryngology (48 citations) and Cancer Research (117 citations). Antonio Rullan has collaborated with scholars based in United Kingdom, Spain and Palestinian Territory. Frequent co-authors include Erik Sahai, Danielle Park, Josep M. Piulats, Ignacio Melero, Alfonso R. Sánchez-Paulete, María E. Rodríguez-Ruiz, Nicola Tinari, Marc Oliva, Kevin J. Harrington and Alan Melcher. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Oncology, Blood, Cancer Treatment Reviews and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.